Generate:Biomedicines Appoints Dr. Alexandra Snyder As Executive Vice President, Research & Development

Jun 12, 2023•about 2 years ago

Position

Founder & Cto

Company

Generate:Biomedicines

Alexandra Snyder

Somerville

Description

Generate:Biomedicines today announced that Dr. Alexandra Snyder has been appointed to Executive Vice President, Research & Development, in addition to her current responsibilities as Chief Medical Officer, effective immediately. In her new role, Dr

Company Information

Company

Generate:Biomedicines

Location

Somerville, Massachusetts, United States

About

Generate:Biomedicines is the first drug generation company pioneering a machine learning-powered generative biology platform with the ability to create new drugs on demand across a wide range of biologic modalities. The Generate Platform – which is a continuous loop to generate, build, measure, and learn – can drastically increase the speed at which targets and therapeutics are identified and validated. This will improve the specificity of target engagement by generated proteins and reduce the time and cost of identifying and developing clinical candidates. Generate:Biomedicines is a clinical stage company that was founded by Flagship Pioneering after two years of foundational research in its Labs unit and launched in 2020. Learn more about Generate:Biomedicines by visiting https://generatebiomedicines.com/ or following the company on Twitter and LinkedIn.

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Related People

Kimberly hidden

Lisa hidden

Alexandra hidden

hidden